Sandoz Group AG (LON:0SAN)

London flag London · Delayed Price · Currency is GBP · Price in CHF
65.54
+3.04 (4.86%)
Feb 12, 2026, 5:04 PM GMT
Market Cap25.67B +57.0%
Revenue (ttm)7.73B +4.7%
Net Income165.69M
EPS0.38
Shares Outn/a
PE Ratio154.91
Forward PE21.44
Dividend0.55 (0.88%)
Ex-Dividend DateApr 17, 2025
Volume88,946
Average Volume216,920
Open65.20
Previous Close62.50
Day's Range64.84 - 67.36
52-Week Range26.99 - 67.34
Beta0.25
RSI58.60
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange London Stock Exchange
Ticker Symbol 0SAN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements